Coca-Cola shares jumped more than 4% after the company posted earnings and revenue that topped analyst expectations. United Technologies advanced nearly 2%.US Marketsread more
The IMF trims its economic growth forecast again as the U.S.-China trade war continues, Brexit worries linger and inflation remains muted.Economyread more
Citigroup thinks Tesla investors hoping for a post-earnings rally later this week should scrutinize a pair of related financial metrics.Investingread more
Olive branches were extended from both China and the U.S. as the two nations are set to restart face-to-face trade negotiations after a month-long truce.Marketsread more
In advance of Amazon's earnings report on Thursday, Craig Johnson says the stock chart is pointing to big gains. Mark Tepper also likes the stock.Trading Nationread more
Lawmakers, industry representatives and advocates are testifying to the Senate committee about the challenges that cannabis companies face in states where medical or...Health and Scienceread more
Coca-Cola topped Wall Street's expectations for earnings and revenue.Food & Beverageread more
New disclosures show Facebook and Amazon each spent more than $4 million on lobbying activity in the second quarter of 2019.Technologyread more
Boris Johnson, one of the biggest voices in the Brexit movement, wins the Conservative Party leadership race by a 2-1 margin.Europe Politicsread more
Disney can nearly double its earnings by 2024, Morgan Stanley said in a note to clients on Tuesday.Investingread more
Amazon is expected to report its second-quarter earnings on Thursday.Investingread more
A U.S. appeals court upheld on Friday an order by a U.S. agency that POM Wonderful cannot advertise that its juices treat or prevent heart disease and other ailments unless it can prove that the assertions are true.
The U.S. Court of Appeals for the D.C. Circuit largely upheld a 2010 order by the Federal Trade Commission which found that POM Wonderful's advertising was misleading in claiming its products would reduce the risk of a variety of diseases.
Read More Chipotle ups bet on fast-casual pizza
The appeals court upheld the FTC decision except for the portion where the FTC required two scientific studies in order to make health claims in advertising, saying that there was "inadequate justification'' for that demand.